Health

Article about clinical testing of the experimental anti-allergy agent Anti-IgE, in a version called rhuMAb-E25.

Information about allergic asthma, how the medication works, and sections for patients, family and friends, and medical professionals.

Includes fact sheet, prescribing information, and how it's manufactured.

Description and analysis of cases of anaphylaxis following omalizumab administration, published in The Journal of Allergy and Clinical Immunology.

Features information about dosage, usage, warnings, and side effects.